Effect of Ruboxistaurin on Clinically Significant Macular Edema

NCT00133952 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

309

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ruboxistaurin
DRUG: Placebo

Sponsor

Chromaderm, Inc.